S&P 500   3,107.51 (-0.41%)
DOW   27,804.07 (-0.47%)
QQQ   201.91 (-0.72%)
CGC   17.56 (+14.62%)
BABA   182.50 (-1.48%)
GE   11.36 (-1.22%)
T   36.99 (-2.68%)
ACB   2.57 (+9.83%)
F   8.70 (-2.25%)
PRI   131.71 (+0.05%)
BAC   32.65 (-0.88%)
DIS   146.66 (-1.16%)
S&P 500   3,107.51 (-0.41%)
DOW   27,804.07 (-0.47%)
QQQ   201.91 (-0.72%)
CGC   17.56 (+14.62%)
BABA   182.50 (-1.48%)
GE   11.36 (-1.22%)
T   36.99 (-2.68%)
ACB   2.57 (+9.83%)
F   8.70 (-2.25%)
PRI   131.71 (+0.05%)
BAC   32.65 (-0.88%)
DIS   146.66 (-1.16%)
S&P 500   3,107.51 (-0.41%)
DOW   27,804.07 (-0.47%)
QQQ   201.91 (-0.72%)
CGC   17.56 (+14.62%)
BABA   182.50 (-1.48%)
GE   11.36 (-1.22%)
T   36.99 (-2.68%)
ACB   2.57 (+9.83%)
F   8.70 (-2.25%)
PRI   131.71 (+0.05%)
BAC   32.65 (-0.88%)
DIS   146.66 (-1.16%)
S&P 500   3,107.51 (-0.41%)
DOW   27,804.07 (-0.47%)
QQQ   201.91 (-0.72%)
CGC   17.56 (+14.62%)
BABA   182.50 (-1.48%)
GE   11.36 (-1.22%)
T   36.99 (-2.68%)
ACB   2.57 (+9.83%)
F   8.70 (-2.25%)
PRI   131.71 (+0.05%)
BAC   32.65 (-0.88%)
DIS   146.66 (-1.16%)
Log in

Adamas Pharmaceuticals Earnings Date, Estimates & History (NASDAQ:ADMS)

$5.34
-0.10 (-1.84 %)
(As of 11/20/2019 03:09 PM ET)
Today's Range
$5.33
Now: $5.34
$5.61
50-Day Range
$3.46
MA: $4.38
$5.63
52-Week Range
$3.35
Now: $5.34
$12.57
Volume14,909 shs
Average Volume353,170 shs
Market Capitalization$148.77 million
P/E RatioN/A
Dividend YieldN/A
Beta1.61

Earnings

Adamas Pharmaceuticals (NASDAQ:ADMS) Earnings Information

Adamas Pharmaceuticals last issued its earnings results on November 7th, 2019. The specialty pharmaceutical company reported ($0.99) EPS for the quarter, missing the consensus estimate of ($0.90) by $0.09. The company earned $13.93 million during the quarter, compared to analyst estimates of $14.36 million. Adamas Pharmaceuticals has generated ($4.87) earnings per share over the last year. Adamas Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 2nd, 2020 based off prior year's report dates.

Adamas Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Adamas Pharmaceuticals (NASDAQ:ADMS) Earnings Estimates

2019 EPS Consensus Estimate: ($4.22)
2020 EPS Consensus Estimate: ($2.77)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20193($1.31)($1.07)($1.21)
Q2 20193($1.22)($0.85)($1.03)
Q3 20193($1.18)($0.87)($1.02)
Q4 20193($1.02)($0.80)($0.95)
Q1 20202($0.96)($0.75)($0.86)
Q2 20202($0.83)($0.62)($0.73)
Q3 20202($0.75)($0.50)($0.63)
Q4 20202($0.71)($0.42)($0.57)
Q1 20211($0.54)($0.54)($0.54)
Q2 20211($0.48)($0.48)($0.48)
Q3 20211($0.44)($0.44)($0.44)

Adamas Pharmaceuticals (NASDAQ ADMS) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
3/2/2020
(Estimated)
       
11/7/20199/30/2019($0.90)($0.99)($0.99)$14.36 million$13.93 millionTranscript
8/8/2019Q2 2019($0.98)($0.90)($0.90)$12.62 million$12.69 millionN/A
5/9/20193/31/2019($1.13)($1.08)($1.08)$12.78 million$11.67 millionN/A
3/4/2019Q4($1.36)($1.06)($1.06)$13.30 million$13.32 millionTranscript
11/1/20189/30/2018($1.34)($1.22)($1.22)$10.10 million$10.61 millionTranscript
8/2/2018Q2 2018($1.41)($1.2570)($1.26)$4.84 million$7.57 millionN/A
5/3/2018Q1 2018($1.37)($1.35)($1.35)$1.71 million$2.55 millionN/A
2/22/2018Q4 2017($1.18)($1.27)($1.27)$0.84 million$0.57 millionN/A
11/2/2017Q3 2017($1.01)($1.04)($1.04)$0.03 millionN/A
8/8/2017Q2 2017($0.81)($0.93)($0.93)$0.03 million$0.02 millionListen
5/9/2017Q1 2017($0.72)($0.72)($0.72)$0.11 millionListen
2/28/2017Q4($0.80)($0.68)($0.68)$0.17 million$0.04 millionN/A
11/3/2016Q3 2016($0.83)($0.66)($0.66)$0.26 million$0.14 millionN/A
8/4/2016Q2 2016($0.71)($0.78)($0.78)$0.18 million$0.22 millionN/A
5/10/2016Q1($0.76)($0.65)($0.65)$0.18 millionN/A
2/23/2016Q4($0.81)($0.58)($0.58)$0.10 million$0.52 millionN/A
11/12/2015Q3($0.79)($0.81)($0.81)$0.10 million$0.77 millionN/A
8/11/2015Q215($0.67)($0.78)($0.78)$0.10 million$0.40 millionN/A
5/13/2015Q414($0.74)($0.69)($0.69)$0.10 million$0.23 millionN/A
3/3/2015Q4 2014$0.64$0.50$0.50$30.18 million$30.30 millionN/A
11/4/2014Q314($0.44)($0.57)($0.57)$0.18 million$0.22 millionN/A
8/7/2014Q214$2.07$0.88$0.88$18.75 million$25.15 millionN/A
5/13/2014Q114($0.09)($0.67)($0.67)$30.60 million$0.18 millionTranscript
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 11/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel